APS

31st APS Annual Convention · 2019

OROS Methylphenidate Is Associated with Improved Attentional Vigilance Among Youth with ADHD

Washington, DC · May 2019

Poster · Clinical Science

Session: Poster Session III

Authors

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent (11%) neurodevelopmental disorder, associated with difficulties with both response inhibition and attentional vigilance. The aim of the current study is to determine whether Osmotic Release Oral System (OROS) Methylphenidate HCL (OROS MPH) improves response inhibition and attentional vigilance among children with ADHD.

Psychopathology